Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Natural antimutagenic agents

L A Mitscher1, H Telikepalli, E McGhee

  • 1Department of Medicinal Chemistry, Kansas University, Lawrence, USA.

Mutation Research
|February 19, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A RAC-GEF network critical for early intestinal tumourigenesis.

Nature communications·2021
Same author

Feeding stimulatory and inhibitory chemicals from an acceptable nonhost plant forManduca sexta: Improved detection by larvae deprived of selected chemosensory organs.

Journal of chemical ecology·2013
Same author

Ongoing in vivo studies with cytoskeletal drugs in tau transgenic mice.

Current Alzheimer research·2006
Same author

The Medicinal and Bioorganic Chemistry Foundation--third winter conference. 23-29 January 1999, Steamboat Springs, CO, USA.

IDrugs : the investigational drugs journal·2005
Same author

Antimutagenic/antioxidant activity of green tea components and related compounds.

Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer·2004
Same author

The ability of certain antimutagenic agents to prevent development of antibiotic resistance.

Mutation research·2001
Same journal

Monoallelic germline RAD51C, RAD51D, and BRIP1 variants in hereditary cancer testing: Variant spectrum and clinical counselling implications.

Mutation research·2026
Same journal

Prediction of hepatocellular carcinoma associated biomarkers in TP53 gene; A comprehensive in silico analysis.

Mutation research·2026
Same journal

IDH1 mutation promotes angiogenesis via upregulation of hypoxia inducible factor 1 alpha in glial tumors.

Mutation research·2026
Same journal

Targeting overexpressed oncogenes in esophageal cancer through miRNA-mediated gene silencing: Insights from binding affinity and thermodynamic profiling.

Mutation research·2026
Same journal

The active compound quercetin from Polygonum cuspidatum targets COL3A1 to enhance CD8⁺ T cell cytotoxicity in gastric cancer.

Mutation research·2026
Same journal

E2F1 promotes LIHC malignant phenotype via NEK2-mediated Wnt/β-catenin and Notch activation and EMT.

Mutation research·2026
See all related articles

Researchers identified novel antimutagenic compounds from medicinal plants. These natural agents show promise in protecting against mutagens in both bacterial and mammalian cell tests, highlighting new screening methods.

Area of Science:

  • Natural Products Chemistry
  • Chemoprevention Research
  • Mutagenesis and Antimutagenesis

Background:

  • Growing interest in natural compounds for cancer prevention and reducing mutagenicity.
  • Previous studies explored medicinal plants for antimutagenic properties.
  • Need for robust screening systems for novel chemopreventive agents.

Purpose of the Study:

  • To investigate contemporary findings on natural antimutagenic and chemopreventive agents.
  • To illustrate underlying principles using ethyl methanesulfonate (EMS) and murine FM3A cells.
  • To evaluate the efficacy of isolated compounds and plant extracts in modified test systems.

Main Methods:

  • Utilized modified Ames tests with the direct-acting mutagen ethyl methanesulfonate (EMS).

Related Experiment Videos

  • Employed eukaryotic murine FM3A mammary tumor cells sensitive to thymidine-less death.
  • Isolated and tested novel antimutagen plicatin B from Psoralea species; analyzed Styrax asiatica extracts.

    • Main Results:

    • Successfully isolated plicatin B, a novel antimutagen, from Psoralea juncaea and P. plicata.
    • Extracts from Styrax asiatica demonstrated antimutagenic activity in FM3A cells, paralleling EMS studies.
    • Identified cinnamic acid, cinnamoyl ricinoleate, and cinnamoyl cinnamate as active agents effective in both prokaryotic and eukaryotic systems.

    Conclusions:

    • Natural compounds like plicatin B, cinnamic acid, and its derivatives possess significant antimutagenic properties.
    • The murine FM3A cell assay system is effective for screening and assaying novel antimutagenic agents.
    • Findings support the potential of these natural agents and assay systems for chemoprevention research.